The company has been selected as a project for enhancing the innovation capability of technology-based small and medium-sized enterprises in Shandong Province

In November 2021, the Science and Technology Department of Shandong Province announced the first batch of approved projects for the 2021 Shandong Province Science and Technology based Small and Medium sized Enterprise Innovation Capability Enhancement Project, and Zhonghan (Qihe County) Biomedical Technology Co., Ltd. was honored to be selected.

The projects announced this time cover multiple high-tech fields, aiming to promote the innovation capability and core competitiveness of technology-based small and medium-sized enterprises in Shandong Province. Zhonghan Biopharmaceutical Technology Co., Ltd. stood out among numerous applicants with its outstanding research and development capabilities and innovative projects, and was successfully selected for this batch of project proposals.

The company has been committed to research and innovation in the field of biomedicine, constantly promoting the development and application of new technologies and products. The company has a high-quality R&D team dedicated to exploring and industrializing cutting-edge technologies in biomedicine. The selected projects further demonstrate the company's outstanding capabilities and industry influence in technological innovation.

The innovation capability enhancement project will provide policy and financial support to selected enterprises to accelerate the transformation and application of scientific and technological achievements. For Zhonghan Biomedical Technology Co., Ltd., this is not only a recognition of its past efforts, but also a strong support for its future development.

The company leader stated that they will make full use of the opportunity presented by this project, increase research and development investment, accelerate project progress, and strive to achieve more breakthrough results in the field of biomedicine. At the same time, the company will actively respond to national policies and contribute to the development of the biopharmaceutical industry in Shandong Province and even the whole country.

The selection of this company not only enhances its brand image and market competitiveness, but also injects new impetus into its innovative development. I believe that in the future development, the company will continue to maintain its innovative spirit and bring more surprises and breakthroughs to the biopharmaceutical industry.